Pearl Receives FDA Clearance for Panoramic AI
Pearl , the global leader in AI solutions for dentistry , recently announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for AI-powered detection of dental pathologies on panoramic radiographs. This latest clearance expands Pearl’s clinically validated radiologic AI technology to the most widely captured extraoral imaging modality in dentistry and is now available to Second Opinion® users in the U.S. and internationally. This clearance marks another major advancement in the company’s mission to elevate diagnostic accuracy, consistency, and efficiency across the full spectrum of dental care. A dentist reviews a panoramic radiograph with support from Pearl’s Second Opinion® AI, now FDA-cleared for automated detection of dental pathologies on panoramic x-rays. Pearl’s Second Opinion real-time, chairside pathology detection platform is now cleared to identify and highlight suspected caries, periapical radio...
